The HPRA advises healthcare professionals not to retain printed versions of Summary of Product Characteristics (SPC) documents. As these documents are subject to frequent content updates, including changes to safety and dose related information, we recommend that you visit our website as necessary to access the most up-to-date versions.If you have any queries about the SPCs on our website then please e-mail vetinfo@hpra.ie


Veloxa XL Chewable Tablets for Dogs

175, 175, 525 mg/tablet Chewable tablet

LAVET Pharmaceuticals LtdVPA10482/003/001

Main Information

Trade NameVeloxa XL Chewable Tablets for Dogs
Active SubstancesPraziquantel
Pyrantel
Febantel
Strength175, 175, 525 mg/tablet
Dosage FormChewable tablet
Licence HolderLAVET Pharmaceuticals Ltd
Licence NumberVPA10482/003/001

Group Information

ATC CodeQP52AA51 praziquantel, combinations
Therapeutic ClassCardiovascular
SpeciesDogs

Status

Authorised/WithdrawnAuthorised
Licence Issued18/01/2013
Legal StatusCAM: Companion Animal Medicine as defined in relevant national legislation

Documents

Summary of Product CharacteristicsPDF Version
Package LeafletNo document available
Public Assessment ReportNo document available
« Back